Kelly, Mark D.

Top Publications

Top Publications Authored or Co-Authored by "Kelly, Mark D."

• Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): A randomised, double-blind, placebo-controlled, non-inferiority trial

  The Lancet, Volume 383, No. 9927, Year 2014, Citations 133
• Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

  PLoS Medicine, Volume 12, No. 3, Article e1001809, Year 2015, Citations 103
• Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study

  The Lancet Infectious Diseases, Volume 15, No. 7, Year 2015, Citations 96
• Dynamics of immunoglobulin sequence diversity in HIV-1 infected individuals

  Philosophical Transactions of the Royal Society B: Biological Sciences, Volume 370, No. 1676, Year 2015, Citations 32
• Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study

  PLoS ONE, Volume 10, No. 10, Article e0139981, Year 2015, Citations 8